51 members named to TBD Working Group subcommittees

From the website of the Department of Health and Human Services:

The Department of Health and Human Services (HHS) announces the names of 51 individuals who have been selected to serve on one of six subcommittees of the Tick-Borne Disease Working Group (Working Group). After reviewing the nominations, selections were made by the co-chairs overseeing each of the subcommittees. The Chair and Vice-Chair of the Working Group provided input and approved the final selections. All of the individuals were notified today, but they have not yet confirmed their availability to serve on the subcommittee that they were chosen to join. The final list of subcommittee members will be updated if any of them are no longer able to join a subcommittee.

These subcommittees were established by the Working Group members during the December 12, 2017 meeting to assist them in identifying and reviewing information that provides the background, context, and evidence needed to develop the report to Congress and the HHS Secretary as required by the 21st Century Cures Act. The subcommittees will be led by members of the Working Group. The Chair and Vice-Chair of the Working Group will work in collaboration with the subcommittee Co-Chairs and the Designated Federal Officer to ensure that the work of the subcommittees is consistent with the needs of the Working Group and committee management laws and regulations. The roles of the subcommittees, the work they will be doing, and the reports that they will provide to the Working Group will discussed at the February 12, 2018 meeting.

The members of the Tick-Borne Disease Working Group subcommittees are:

Disease Vectors, Surveillance, and Prevention
Co-Chairs: Pat Smith and Ben Beard, MS, PhD


  • Jill Auerbach Founder, Tick Research to Eliminate Diseases
    Founder, Stop Ticks On People (S.T.O.P.)
  • Neeta Connally, PhD, MSPH Associate Professor, Tick-borne Disease Prevention Laboratory, Western Connecticut State
  • Katherine Feldman, DVM, MPH Senior Epidemiologist, MITRE
  • Thomas N. Mather, PhD Professor, Center for Vector-Borne Disease
    Director, TickEncounter Resource Center
  • Phyllis Mervine President,
  • Colonel Robin Nadolny, PhD COL, Medical Service Team Lead, Tick-Borne Disease Laboratory, Army Public Health Center
  • Adalberto Perez de Leon, DVM, PhD, MS Director, Knipling-Bushland U.S. Livestock Insects Research Laboratory, United States Department of Agriculture-Agricultural Research Service
  • Daniel E. Sonenshine, PhD Eminent Professor of Biological Science, Old Dominion University
  • Jean I. Tsao, PhD Associate Professor, Departments of Fisheries and Wildlife and of Large Animal Clinical Sciences, Michigan State University
  • Monica M. White President and Co-founder, Colorado Tick-Borne Disease Awareness Association, Lyme Disease Association, Inc., Public Tick IPM working group, Chaffee County Health Coalition
  • Stephen Wikel, PhD Professor and Chair Emeritus of Medical Sciences, St. Vincent’s Medical Center, Quinnipiac University

Pathogenesis, Transmission and Treatment
Co-Chairs: Wendy Adams, MBA and Captain Estella Jones, DVM


  • Nicole Baumgarth, DVM, PhD Professor, Center for Comparative Medicine and Dept. of Pathology, Microbiology & Immunology, UC Davis
  • Patricia K. Coyle, MD Neurology Professor and Vice Chair, Dept. of Neurology
    Director, MS Comprehensive Care Center, Stony Brook University Medical Center
  • Sam Donta, MD Fellow Infectious Diseases, Infectious Disease Society of America
    Consultant, Infectious Diseases
  • Brian Fallon, MD, MPH Professor of Clinical Psychiatry, and Director, Lyme and Tick-Borne Diseases Research Center, Columbia University
  • Lorraine Johnson, JD, MBA CEO,
  • Elizabeth Maloney, MD President, Partnership for Tick-Borne Diseases Education
  • Jon Skare, PhD Professor and Associate Head, Dept. of Microbial Pathogenesis and Immunology, Texas A & M University
  • Brian Stevenson, PhD Professor, Department of Microbiology, Immunology & Molecular Genetics, University of Kentucky College of Medicine

Testing and Diagnostics
Co-Chairs: Lise E. Nigrovic, MD, MPH and Co-chair to be determined


  • Charles Y. Chiu, MD, PhD Director, Abbott Viral Diagnostics and Discovery Center, UCSF
  • Roberta DeBiasi, MD, MS Chief, CNMC Division of Pediatric Infectious Diseases
    Director, Fetal Infectious Diseases Program, Co-Director, Congenital Zika Program at Children’s National
  • Noel Gerald, PhD Biologist and Senior Scientific Reviewer, Office of In Vitro Diagnostics and Radiological Health, FDA
  • Deborah Hoadley, MD, MPH Director, New England Institute for Lyme Disease and Tick-Borne Illnesses
  • Maliha Ilias, PhD Program Officer, Lyme Disease Research Bacteriology and Mycology Branch, National Institute of Infectious Diseases, NIH
  • Bobbi Pritt, MD, MSc Professor of Laboratory Medicine and Pathology, and Co-Director, Vector-Borne Diseases Laboratory Services,  Mayo Clinic
  • David Roth, JD Retired senior managing director of a private equity firm (Blackstone)
  • Steven Schutzer, MD Professor of Medicine, Rutgers New Jersey Medical School

Access to Care Services and Support to Patients
Co-Chairs: Karen Vanderhoof-Forschner, JD, MBA and Commander Scott Cooper, MMSc, PA-C


  • Ana Frost, PhD The Institute for Functional Medicine
  • Holiday Goodreau President and Executive Director, The LiveLyme Foundation
  • Susan Green, JD Legislative Counsel, NatCapLyme
  • Enid Haller, LCSW, PhD Executive Director, Lyme Center of Martha’s Vineyard
    Martha’s Vineyard Lyme Support Group
  • Paula Jones Jackson President & Co-Founder, Midcoast Lyme Disease Support & Education (MLDSE)
  • Colonel Nicole Malachowski Retired, US Air Force
  • Leonard Schuchman, DO, MPH, FAAFP Osteopathic Physician
  • Sheila M. Statlender, PhD Clinical Psychologist, Private Practice
  • Kathleen Steele, LCSW Psychotherapist

Vaccine and Therapeutics
Co-Chairs: Robert Smith, MD, MPH, FACP, FIDSA and Dennis Dixon, PhD


  • Monica E. Embers, PhD Assistant Professor, and Director, TNPRC Vector-borne Diseases Core, Division of Bacteriology and Parasitology, Tulane National Primate Research Center
  • Maria Gomes-Solecki, PhD Associate Professor, Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center
  • Utpal Pal, PhD Professor, University of Maryland
  • Stanley A. Plotkin, MD Emeritus Professor of Pediatrics, University of Pennsylvania
  • Juan Salazar, MD, MPH, FAAP Professor and Chair, Department of Pediatrics, University of Connecticut Medical School, and Physician in Chief and Executive VP, Connecticut Children’s Medical Center
  • Leigh Ann Soltysiak, MS Self-employed, Owner, Principal Commercialization & Strategy Consultant, Silverleaf Consulting, LLC
  • David H. Walker, MD The Carmage and Martha Walls Distinguished University Chair in Tropical Diseases, and Professor, Department of Pathology, and Executive Director, Center for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch

Other Tick-Borne Diseases and Co-Infections
Co-Chairs: Richard Horowitz, MD and Allen Richards, PhD


  • Megan Dulaney, MS Senior Interagency Liaison, DOD Center for Health Engagement, Uniformed Services University for the Health Sciences, Henry M. Jackson Foundation for the Advancement of Military Medicine
  • Marna Ericson, PhD Assistant Professor, Department of Dermatology, and Director, Dermatology Imaging Center, University of Minnesota
  • Christine Green, MD Physician, Green Oaks Medical Center, PC, and Director,
  • Charles Lubelczyk, MPH Vector Ecologist, Maine Medical Center Research Institute
  • Ulrike G. Munderloh, DVM, PhD Professor, University of Minnesota, Department of Entomology
  • Christopher D. Paddock, MD, MPHTM Rickettsial Zoonoses Branch, CDC
  • Samuel S. Perdue, PhD Section Chief, Basic Sciences, Bacteriology and Mycology Branch, DMID/NIAID/NIH
  • Sam R. Telford III, ScD Professor of Infectious Disease and Global Health
    Cummings School of Veterinary Medicine, Tufts University


For more on what the Working Group does:

Some downsides of the 21st CCA:  The 21st Century Cures Act introduced in 2015 and expanded in 2016 weakens informed consent protections for people participating in experimental vaccine clinical trials. It allows drug companies to use surrogate endpoints to evaluate the effectiveness of vaccines and permits the FDA to accept novel statistical analyses and clinical experience related to a new vaccine’s reactivity, instead of requiring drug companies to conduct large randomized clinical trials to demonstrate safety. It prevents vaccine manufacturers from being sued in civil court if an FDA licensed vaccine given to a pregnant woman causes the injury or death of her unborn child in the womb.